Which iShares Bond ETF Is the Better Buy: Treasury-Focused IEI or Corporate IGIB?

iShares IGIB (5-10Y investment-grade corporates) screens higher yield at 4.90% versus IEI (3-7Y Treasuries) at 3.70%, while also charging a lower expense ratio (0.04% vs 0.15%). Over the last 5 years, IGIB shows higher risk with a larger max drawdown (20.60% vs 13.90%) and slightly lower growth of $1,000 to $1,045 vs $1,003 for IEI. The article frames the trade-off as lower cost and more income for IGIB against greater stability and equity decorrelation for IEI, given corporate credit spreads near historic lows.

Analysis

The real signal is not the yield gap; it is the amount of hidden equity beta investors are taking on to earn that incremental carry. IGIB should attract assets in a benign-rate, low-volatility regime because fee drag is trivial and the spread pickup still screens well versus cash-like alternatives, but that advantage is fragile when equity volatility or recession odds rise. IEI is the cleaner ballast asset: it has less upside in a rally, but it preserves diversification exactly when credit funds tend to fail as hedges.

Second-order effects matter more than the fund comparison itself. IGIB is effectively a levered bet on stable funding markets for banks like BAC and WFC and on resilient balance sheets for mega-cap issuers such as META; that is supportive in a soft-landing narrative, but it also means any widening in corporate spreads can transmit quickly from rates into broad credit technicals. The market is currently paying very little for that protection gap, so the downside asymmetry in IGIB is not the carry, it is the convexity of spread widening from tight levels.

The contrarian view is that investors may be over-optimizing on fee and headline yield while underweighting correlation in the next risk-off episode. Over the next 1-3 months, the key catalyst is whether macro data or Fed communication re-anchors rate volatility; over 6-18 months, the regime question is whether cuts arrive with soft landing or credit deterioration. If IGIB spreads stay pinned and equity vols remain subdued, the relative-value case for IGIB improves; if VIX and CDX IG both move up together, IEI should outperform decisively.

Key Decisions for Investors

• No immediate outright trade on the article alone; the edge is too small unless macro volatility is already rising. Use this as a watch item rather than forcing allocation.
• Tactical pair for the next 2-6 weeks: long IEI / short IGIB if growth data softens or equity vol spikes. Target a 1-2% relative move in favor of IEI; invalidate if IGIB credit spreads remain flat and IGIB outperforms by more than 1% on a risk-on tape.
• If mandates require income and volatility stays contained, rotate marginal duration exposure from IEI into IGIB in small size. The trade works only if spreads remain tight and the Fed stays on a benign-cut path; reassess after the next CPI/FOMC window.
• Watch bank credit proxies BAC and WFC CDS/OAS as the first falsifier for IGIB. A 10-15 bps widening there is an early warning that the ETF’s carry is being overwhelmed by spread risk.
• Set an alert on IGIB vs IEI relative performance after major macro prints; if IGIB starts lagging during a market drawdown, treat that as confirmation that the 'yield pickup' is no longer paying for the embedded equity beta.